Reno, United States
Conexeu Sciences Inc. is a pioneering entity in regenerative medicine, aiming to transform tissue repair and longevity through cutting-edge innovation. Founded in 2022, the company capitalizes on over a decade of university research. Its flagship product, Ten Minute Tissue™, is a patented collagen-based extracellular matrix engineered to enhance tissue healing and integration.
Conexeu's revolutionary platform, known as CXU™, presents significant opportunities across multi-billion-dollar markets. The product's ability to form a thermosensitive scaffold that supports structured tissue growth makes it a formidable potential player in the fields of Biopharma and Biotechnology.
With headquarters in the United States and patents across the U.S., E.U., Japan, and Australia, Conexeu is strategically positioned for global growth. The company recently secured a Seed Round investment in December 2023, underscoring investor confidence in its transformative potential, though specific investor names have not been disclosed.
